Electron microscopy in the diagnosis of lysosomal storage diseases
- PMID: 2835968
- DOI: 10.1002/ajmg.1320280529
Electron microscopy in the diagnosis of lysosomal storage diseases
Abstract
Lysosomal storage diseases (LSD) affect cells of the conjunctiva in the absence of clinical eye findings. Consequently conjunctiva was added to skin, rectal mucosa, and peripheral blood lymphocytes as a biopsy site for electron microscopic examination in suspected LSD. The abnormally stored substrates in LSD are the result of diminished lysosomal enzyme activity. Although all cells lack the deficient lysosomal enzyme, the quantity of stored material varies with the extent of breakdown of substrate in the cell under normal circumstances. The stored material does not accumulate in all cells and may have a different cellular morphology at different sites. Although no one tissue provides universally diagnostic material for electron microscopy, skin and conjunctiva are optimal for most LSD. Rectal mucosa and peripheral blood lymphocytes are also useful in many cases. Biochemical assays have replaced brain biopsy for diagnosis but these techniques may give equivocal or non-diagnostic results, and in some diseases the enzyme defect remains undefined. Of the 359 biopsies of conjunctiva, skin, rectal mucosa, and lymphocytes we evaluated for LSD and other neurodegenerative diseases, 65 showed abnormal lysosomal storage; in 41 a specific diagnosis was made by biochemical assay or morphology. Ultrastructural examination of tissue from patients with clinically suspected storage disease may disclose pathognomonic alterations or suggest a differential diagnosis even in the absence of clinically evident involvement of the biopsied tissue. Biopsy has particular value in those diseases with incompletely characterized biochemical abnormalities.
Similar articles
-
The diagnostic value of ultrastructural studies of skin-punch biopsies and buffy coat for the early diagnosis of some neurodegenerative diseases.Ann N Y Acad Sci. 1986;477:285-311. doi: 10.1111/j.1749-6632.1986.tb40349.x. Ann N Y Acad Sci. 1986. PMID: 3028228 No abstract available.
-
Intraepidermal morphologic manifestations in lysosomal diseases.Brain Dev. 1989;11(5):338-41. doi: 10.1016/s0387-7604(89)80065-8. Brain Dev. 1989. PMID: 2554741
-
Diagnosis of lysosomal storage diseases by the ultrastructural study of conjunctival biopsies.Pathol Annu. 1980;15(Pt 1):37-66. Pathol Annu. 1980. PMID: 7443310
-
Storage diseases: diagnostic position.Ultrastruct Pathol. 2013 Feb;37(1):19-22. doi: 10.3109/01913123.2012.670060. Ultrastruct Pathol. 2013. PMID: 23383614 Review.
-
Diagnostic morphology of human eye-related storage disorders.Ophthalmic Paediatr Genet. 1989 Sep;10(3):199-209. doi: 10.3109/13816818909009876. Ophthalmic Paediatr Genet. 1989. PMID: 2685704 Review.
Cited by
-
Phenotypic Screening Using High-Content Imaging to Identify Lysosomal pH Modulators in a Neuronal Cell Model.ACS Chem Neurosci. 2022 May 18;13(10):1505-1516. doi: 10.1021/acschemneuro.1c00804. Epub 2022 May 6. ACS Chem Neurosci. 2022. PMID: 35522480 Free PMC article.
-
Niemann-Pick C-like Endolysosomal Dysfunction in DHDDS Patient Cells, a Congenital Disorder of Glycosylation, Can Be Treated with Miglustat.Int J Mol Sci. 2025 Feb 10;26(4):1471. doi: 10.3390/ijms26041471. Int J Mol Sci. 2025. PMID: 40003936 Free PMC article.
-
Drug-induced lysosomal disorders in laboratory animals: new substances acting on lysosomes.Arch Toxicol. 1992;66(1):23-33. doi: 10.1007/BF02307266. Arch Toxicol. 1992. PMID: 1349805
-
Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation.Pharm Res. 2012 Aug;29(8):2249-63. doi: 10.1007/s11095-012-0753-1. Epub 2012 Apr 27. Pharm Res. 2012. PMID: 22538436
-
The renal biopsy in the genomic era.Pediatr Nephrol. 2013 Aug;28(8):1207-19. doi: 10.1007/s00467-012-2356-9. Epub 2012 Nov 21. Pediatr Nephrol. 2013. PMID: 23179194 Review.